You are here: homepage –
The best month ever!
With a plus of 13.11%, our fund set a new monthly record in November! Euphorized by the vote out of U.S. President Donald Trump and especially by positive clinical data on corona vaccines from Pfizer/Biontech and Moderna, global stock markets have skyrocketed this month. The study results so far are promising, but at the same time it will take months before the general population can be vaccinated. Nonetheless, the topic of corona seems to have been eaten by many investors and the economic recovery in 2021 is in the spotlight.
We have also increased the proportion of cyclical stocks over the course of the month, while at the same time slightly expanding our hedging. Our fund is quoted ytd. +3.11%.
Book an initial consultation now
Gladly in person or digitally, conveniently and easily from home. Conserving resources without the expense of travel.
You are here: homepage –
More articles on asset management
Monthly Report for May 2026
Monthly report May 2026 Once again, May was shaped by geopolitical factors. Ongoing discussions about the Strait of Hormuz—now known worldwide—as well as fragile ceasefires in the Middle East dominated the scene. Contrary to the old stock...
Monthly report March 2026
Monthly report March 2026 At the start of the month, the stock markets reacted with heavy losses to the US and Israeli air strikes against Iran. Iran subsequently retaliated with missile and drone attacks against Israel and also against uninvolved...
Monthly report February 2026
Monthly report February 2026 At the beginning of the month, the usefulness and economic viability of the huge investment plans of leading tech companies once again became a topic of discussion. Software companies in particular saw their share...